Elizabeth Jennings

Elizabeth Jennings is the Founder and Principal of Venture Atlas Labs, a global consultancy specialized in commercial optimization and risk mitigation in emerging markets. Leveraging experience launching new technologies in Healthcare and Life Science in some of the most complex and challenging regions worldwide, she now focuses on applying proprietary methodologies and frameworks to develop the most successful commercial and market scenarios for international trade organizations, venture capital, and private equity. Alongside her team on three continents, she also supports clients through building strategic international partnerships and collaborations among university, government, and private sectors.

In addition to several advisory roles with various accelerators and institutions, such as MassChallenge Texas and the Texas Medical Center Accelerator (TMCx), she frequently speaks on investment and innovation within regulated industries and hosts community events with institutions like Dell Medical School. She is an avid supporter of the IC^2 Institute at the University of Texas at Austin, an industry advisor for the National Science Foundations I-Corps, and a board member for a handful of medical device, in-vitro diagnostics, and AI startups. She also supports a number of organizations addressing critical international development and neglected tropical disease issues.

With nearly a decade living in South America and Europe, she speaks Spanish and Italian reasonably well, and Portuguese, French, and Dutch with good intentions.